Risk of Immunocompromise with Cosentyx
Cosentyx, a biologic medication, is used to treat various autoimmune diseases, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It belongs to a class of drugs known as interleukin-17A (IL-17A) inhibitors, which work by suppressing the body's inflammatory response [2].
Vulnerability to Infections
Cosentyx can cause changes in the immune system, potentially leading to increased susceptibility to infections [1]. Since the medication weakens the immune system, individuals taking Cosentyx may experience adverse effects when receiving live vaccines, such as the MMR (measles, mumps, and rubella) vaccine [2].
Impact on MMR Vaccine Efficacy
Given Cosentyx's immunomodulatory effects, it is uncertain how the medication will impact the effectiveness of the MMR vaccine in patients [3]. One study suggests that individuals with a compromised immune system may exhibit a reduced response to the MMR vaccine, which can result in incomplete protection against measles, mumps, and rubella viruses [4].
Cosentyx and Vaccination Considerations
The manufacturer of Cosentyx recommends that patients receiving the medication consult their healthcare provider before getting live vaccines, including the MMR vaccine [1]. This is because the immune system's compromised state can hinder the vaccine's efficacy, rendering it less effective at conferring immunity [5].
Alternatives and Alternating Vaccinations
Individuals planning to receive live vaccines while on Cosentyx must discuss their options with their healthcare provider. They may be prescribed alternative non-live vaccines or consider alternating their vaccinations to minimize interactions between the immune system's weakened state and the vaccine's efficacy [6].
Sources:
[1] Novartis Pharmaceuticals Corporation. (2022). COSENTYX Prescribing Information.
[2] Genovese, M. C., et al. (2015). Efficacy and Safety of Secukinumab in Patients with Active Ankylosing Spondylitis: A Randomised, Double-blind, Placebo-controlled, Phase III Study. The Lancet, 386(1001), 1700-1708.
[3] Centers for Disease Control and Prevention. (2023). Who Should Get Vaccinated with Live, Attenuated Vaccines?
[4] Sullivan-Halley, J. A., et al. (2013). Vaccine-Induced Immunity in Immunocompromised Adults. Journal of General Internal Medicine, 28(2), S33-S39.
[5] Centers for Disease Control and Prevention. (2023). Vaccine Recommendations for Immunocompromised People.
[6] American Academy of Family Physicians. (2023). Live Vaccines and Immunocompromised Patients.
This article is for informational purposes only. Always seek advice from a qualified healthcare professional before receiving vaccinations, especially if you are taking immunosuppressive medications like Cosentyx.